Home Carboxys 2-Piperidinecarboxylicacid, 4-(phosphonomethyl)-, (2R,4S)-rel-

2-Piperidinecarboxylicacid, 4-(phosphonomethyl)-, (2R,4S)-rel-

CAS No.:
110347-85-8
Catalog Number:
AG0083Z4
Molecular Formula:
C7H14NO5P
Molecular Weight:
223.1635
Pack Size
Purity
Availability
Location
Price(USD)
Quantity
  
Product Description
Catalog Number:
AG0083Z4
Chemical Name:
2-Piperidinecarboxylicacid, 4-(phosphonomethyl)-, (2R,4S)-rel-
CAS Number:
110347-85-8
Molecular Formula:
C7H14NO5P
Molecular Weight:
223.1635
MDL Number:
MFCD06795863
IUPAC Name:
(2S,4R)-4-(phosphonomethyl)piperidine-2-carboxylic acid
InChI:
InChI=1S/C7H14NO5P/c9-7(10)6-3-5(1-2-8-6)4-14(11,12)13/h5-6,8H,1-4H2,(H,9,10)(H2,11,12,13)/t5-,6+/m1/s1
InChI Key:
LPMRCCNDNGONCD-RITPCOANSA-N
SMILES:
OC(=O)[C@@H]1NCC[C@@H](C1)CP(=O)(O)O
UNII:
N0905W44Y3
Properties
Complexity:
263  
Compound Is Canonicalized:
Yes
Covalently-Bonded Unit Count:
1  
Defined Atom Stereocenter Count:
2  
Defined Bond Stereocenter Count:
0
Exact Mass:
223.061g/mol
Formal Charge:
0
Heavy Atom Count:
14  
Hydrogen Bond Acceptor Count:
6  
Hydrogen Bond Donor Count:
4  
Isotope Atom Count:
0
Molecular Weight:
223.165g/mol
Monoisotopic Mass:
223.061g/mol
Rotatable Bond Count:
3  
Topological Polar Surface Area:
107A^2
Undefined Atom Stereocenter Count:
0
Undefined Bond Stereocenter Count:
0
XLogP3:
-3.9  
Literature
Title Journal
A review of neuroprotection pharmacology and therapies in patients with acute traumatic brain injury. CNS drugs 20120701
Pre-synaptic glycine GlyT1 transporter--NMDA receptor interaction: relevance to NMDA autoreceptor activation in the presence of Mg2+ ions. Journal of neurochemistry 20110501
Pathophysiology, treatment, and animal and cellular models of human ischemic stroke. Molecular neurodegeneration 20110101
Cerebral perfusion pressure, microdialysis biochemistry and clinical outcome in patients with traumatic brain injury. BMC research notes 20110101
Discovery of {1-[4-(2-{hexahydropyrrolo[3,4-c]pyrrol-2(1H)-yl}-1H-benzimidazol-1-yl)piperidin-1-yl]cyclooctyl}methanol, systemically potent novel non-peptide agonist of nociceptin/orphanin FQ receptor as analgesic for the treatment of neuropathic pain: design, synthesis, and structure-activity relationships. Bioorganic & medicinal chemistry 20101101
Integrative emphases on intimate, intrinsic propensity/pathological processes--causes of self recovery limits and also, subtle related targets for neuroprotectionl pleiotropicity/multimodal actions, by accessible therapeutic approaches--in spinal cord injuries. Journal of medicine and life 20100815
Resistin is associated with mortality in patients with traumatic brain injury. Critical care (London, England) 20100101
NMDA-mediated modulation of dopamine release is modified in rat prefrontal cortex and nucleus accumbens after chronic nicotine treatment. Journal of neurochemistry 20090101
Molecular mechanisms of traumatic brain injury: the missing link in management. World journal of emergency surgery : WJES 20090101
Cerebral vasospasm following traumatic subarachnoid hemorrhage. Journal of research in medical sciences : the official journal of Isfahan University of Medical Sciences 20090101
Risks associated with magnetic resonance imaging and cervical collar in comatose, blunt trauma patients with negative comprehensive cervical spine computed tomography and no apparent spinal deficit. Critical care (London, England) 20080101
Pharmacology of traumatic brain injury: where is the 'golden bullet'? Molecular medicine (Cambridge, Mass.) 20080101
Repeated treatment with N-methyl-d-aspartate antagonists in neonatal, but not adult, rats causes long-term deficits of radial-arm maze learning. Brain research 20070912
Increased cerebral oxygen consumption in Eker rats and effects of N-methyl-D-aspartate blockade: Implications for autism. Journal of neuroscience research 20070815
Intracranial pressure monitoring in intensive care: clinical advantages of a computerized system over manual recording. Critical care (London, England) 20070101
NMDA receptor activity in learning spatial procedural strategies I. The influence of hippocampal lesions. Brain research bulletin 20061016
NMDA receptor activity in learning spatial procedural strategies II. The influence of cerebellar lesions. Brain research bulletin 20061016
Acute D2/D3 dopaminergic agonism but chronic D2/D3 antagonism prevents NMDA antagonist neurotoxicity. Biological psychiatry 20060915
Neuroprotection associated with alternative splicing of NMDA receptors in rat cortical neurons. British journal of pharmacology 20060301
Some prognostic models for traumatic brain injury were not valid. Journal of clinical epidemiology 20060201
The NMDA receptor antagonist CGS 19755 disrupts recovery following cerebellar lesions. Restorative neurology and neuroscience 20060101
Glutamate receptors in neuroinflammatory demyelinating disease. Mediators of inflammation 20060101
Severe brain injury ICU outcomes are associated with Cranial-Arterial Pressure Index and noninvasive Bispectral Index and transcranial oxygen saturation: a prospective, preliminary study. Critical care (London, England) 20060101
2-n-Butyl-9-methyl-8-[1,2,3]triazol-2-yl-9H-purin-6-ylamine and analogues as A2A adenosine receptor antagonists. Design, synthesis, and pharmacological characterization. Journal of medicinal chemistry 20051103
Methodological quality of animal studies on neuroprotection in focal cerebral ischaemia. Journal of neurology 20050901
Development of a three-dimensional model for the N-methyl-D-aspartate NR2A subunit. Journal of medicinal chemistry 20050825
Cognitive effects of dopaminergic and glutamatergic blockade in nucleus accumbens in pigeons. Pharmacology, biochemistry, and behavior 20050801
Homocysteine, a risk factor for atherosclerosis, biphasically changes the endothelial production of kynurenic acid. European journal of pharmacology 20050711
Effects of the N-methyl-D-aspartate receptor antagonist perzinfotel [EAA-090; [2-(8,9-dioxo-2,6-diazabicyclo[5.2.0]non-1(7)-en-2-yl)-ethyl]phosphonic acid] on chemically induced thermal hypersensitivity. The Journal of pharmacology and experimental therapeutics 20050601
The NMDA receptor complex: a long and winding road to therapeutics. IDrugs : the investigational drugs journal 20050301
Cerebral perfusion pressure and risk of brain hypoxia in severe head injury: a prospective observational study. Critical care (London, England) 20050101
Acute nociceptive somatic stimulus sensitizes neurones in the spinal cord to colonic distension in the rat. The Journal of physiology 20041001
Neuroprotection against ischemic/hypoxic brain damage: blockers of ionotropic glutamate receptor and voltage sensitive calcium channels. Current drug targets 20041001
Nicotine exerts a permissive role on NMDA receptor function in hippocampal noradrenergic terminals. Neuropharmacology 20040701
The rise and fall of NMDA antagonists for ischemic stroke. Current molecular medicine 20040301
Lessons from epidemiologic studies in clinical trials of traumatic brain injury. Acta neurochirurgica. Supplement 20040101
NMDA-evoked consumption and recovery of mitochondrially targeted aequorin suggests increased Ca2+ uptake by a subset of mitochondria in hippocampal neurons. Brain research 20031212
Cannabinoid CB1 receptor activation does not prevent the toxicity of glutamate towards embryonic chick telencephalon primary cultures. Comparative biochemistry and physiology. Toxicology & pharmacology : CBP 20031101
Neuroprotective effects of N-methyl-D-aspartate receptor antagonist on aspartate induced neurotoxicity in the spinal cord in vivo. The Japanese journal of thoracic and cardiovascular surgery : official publication of the Japanese Association for Thoracic Surgery = Nihon Kyobu Geka Gakkai zasshi 20031001
Glutamate receptor antagonists modulate heat shock protein response in focal brain ischemia. Neurological research 20030301
Stroke: trial by jury. European neurology 20030101
Excitatory amino acid antagonists for acute stroke. The Cochrane database of systematic reviews 20030101
Why did NMDA receptor antagonists fail clinical trials for stroke and traumatic brain injury? The Lancet. Neurology 20021001
Multisubstrate analogue inhibitors of glucosamine-6-phosphate synthase from Candida albicans. Bioorganic & medicinal chemistry letters 20020916
Neuroprotective agents in acute ischemic stroke. The Journal of the Association of Physicians of India 20020201
Antiepileptic drugs and agents that inhibit voltage-gated sodium channels prevent NMDA antagonist neurotoxicity. Molecular psychiatry 20020101
Glutamate AMPA receptor antagonist treatment for ischaemic stroke. Current medical research and opinion 20020101
Effects of antagonism of NMDA receptors on transient lower esophageal sphincter relaxations in the dog. European journal of pharmacology 20011116
Design, synthesis, SAR, and biological evaluation of highly potent benzimidazole-spaced phosphono-alpha-amino acid competitive NMDA antagonists of the AP-6 type. Journal of medicinal chemistry 20010510
A comparative assessment of the efficacy and side-effect liability of neuroprotective compounds in experimental stroke. Brain research 20010223
Regional distribution and pharmacological characteristics of [3H]N-acetyl-aspartyl-glutamate (NAAG) binding sites in rat brain. Neurochemistry international 20010101
The 26th Congress of the Scandinavian Society of Anaesthesiology and Intensive Care Medicine, Tromso, Norway, 13-17 June 2001. Critical care (London, England) 20010101
Anticonvulsant efficacy of N-methyl-D-aspartate antagonists against convulsions induced by cocaine. The Journal of pharmacology and experimental therapeutics 19990501
NMDA antagonists potentiate scopolamine-induced amnesic effect. Behavioural brain research 19970201
Glutamatergic antagonism: effects on lidocaine-induced seizures in the rat. Anesthesia and analgesia 19941001
Yohimbine-induced seizures involve NMDA and GABAergic transmission. Neuropharmacology 19920401
Properties